谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

VP5-2024: Eftilagimod Alpha (soluble LAG-3) and Pembrolizumab in First-Line Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Primary Results from Cohort B (CPS Less-Than 1) of the TACTI-003 Study

R. Metcalf,S. Laban,C.A. Kristensen,T-E. Ciuleanu,I. Braña,A. Soria Rivas,S.M. Dieter,A. Bols,M.D. Forster, M.R. Covela, J. Christian,F.D. Vogl, C. Mueller,F. Triebel

Annals of Oncology（2024）

引用 0|浏览1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要